Intrommune
Mr. Nelson graduated from Cornell University and received his J.D. from New York University School of Law. He has a background in law, finance and management. Previously, he was an analyst at Barclays Capital and ING, was an investment banker at Westwood Capital and CIBC World Markets and practiced law at Willkie Farr & Gallagher and Dewey Ballantine.
Intrommune
Intrommune Therapeutics is a specialty biopharmaceutical company located in New York, NY. Intrommune is developing a revolutionary new treatment platform for food allergies that is safe, effective and convenient.